Matrix Metalloproteinases in Myocardial Infarction and Heart Failure

Kristine Y. DeLeon-Pennell, Cesar A. Meschiari, Mira Jung, Merry L. Lindsey

Research output: Chapter in Book/Report/Conference proceedingChapter

37 Citations (Scopus)

Abstract

Cardiovascular disease is the leading cause of death, accounting for 600,000 deaths each year in the United States. In addition, heart failure accounts for 37% of health care spending. Matrix metalloproteinases (MMPs) increase after myocardial infarction (MI) and correlate with left ventricular dysfunction in heart failure patients. MMPs regulate the remodeling process by facilitating extracellular matrix turnover and inflammatory signaling. Due to the critical role MMPs play during cardiac remodeling, there is a need to better understand the pathophysiological mechanism of MMPs, including the biological function of the downstream products of MMP proteolysis. Future studies developing new therapeutic targets that inhibit specific MMP actions to limit the development of heart failure post-MI are warranted. This chapter focuses on the role of MMPs post-MI, the efficiency of MMPs as biomarkers for MI or heart failure, and the future of MMPs and their cleavage products as targets for prevention of post-MI heart failure.

Original languageEnglish (US)
Title of host publicationProgress in Molecular Biology and Translational Science
PublisherElsevier B.V.
Pages75-100
Number of pages26
DOIs
StatePublished - Jan 1 2017

Publication series

NameProgress in Molecular Biology and Translational Science
Volume147
ISSN (Print)1877-1173
ISSN (Electronic)1878-0814

Fingerprint

Matrix Metalloproteinases
Heart Failure
Myocardial Infarction
Left Ventricular Dysfunction
Proteolysis
Extracellular Matrix
Cause of Death
Cardiovascular Diseases
Biomarkers
Delivery of Health Care

Keywords

  • Fibrosis
  • Heart failure
  • Inflammation
  • Matrix metalloproteinases
  • Myocardial infarction
  • Omics

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Cite this

DeLeon-Pennell, K. Y., Meschiari, C. A., Jung, M., & Lindsey, M. L. (2017). Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. In Progress in Molecular Biology and Translational Science (pp. 75-100). (Progress in Molecular Biology and Translational Science; Vol. 147). Elsevier B.V.. https://doi.org/10.1016/bs.pmbts.2017.02.001

Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. / DeLeon-Pennell, Kristine Y.; Meschiari, Cesar A.; Jung, Mira; Lindsey, Merry L.

Progress in Molecular Biology and Translational Science. Elsevier B.V., 2017. p. 75-100 (Progress in Molecular Biology and Translational Science; Vol. 147).

Research output: Chapter in Book/Report/Conference proceedingChapter

DeLeon-Pennell, KY, Meschiari, CA, Jung, M & Lindsey, ML 2017, Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. in Progress in Molecular Biology and Translational Science. Progress in Molecular Biology and Translational Science, vol. 147, Elsevier B.V., pp. 75-100. https://doi.org/10.1016/bs.pmbts.2017.02.001
DeLeon-Pennell KY, Meschiari CA, Jung M, Lindsey ML. Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. In Progress in Molecular Biology and Translational Science. Elsevier B.V. 2017. p. 75-100. (Progress in Molecular Biology and Translational Science). https://doi.org/10.1016/bs.pmbts.2017.02.001
DeLeon-Pennell, Kristine Y. ; Meschiari, Cesar A. ; Jung, Mira ; Lindsey, Merry L. / Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. Progress in Molecular Biology and Translational Science. Elsevier B.V., 2017. pp. 75-100 (Progress in Molecular Biology and Translational Science).
@inbook{8c7fe96e5b444d4a8b40025ea7358164,
title = "Matrix Metalloproteinases in Myocardial Infarction and Heart Failure",
abstract = "Cardiovascular disease is the leading cause of death, accounting for 600,000 deaths each year in the United States. In addition, heart failure accounts for 37{\%} of health care spending. Matrix metalloproteinases (MMPs) increase after myocardial infarction (MI) and correlate with left ventricular dysfunction in heart failure patients. MMPs regulate the remodeling process by facilitating extracellular matrix turnover and inflammatory signaling. Due to the critical role MMPs play during cardiac remodeling, there is a need to better understand the pathophysiological mechanism of MMPs, including the biological function of the downstream products of MMP proteolysis. Future studies developing new therapeutic targets that inhibit specific MMP actions to limit the development of heart failure post-MI are warranted. This chapter focuses on the role of MMPs post-MI, the efficiency of MMPs as biomarkers for MI or heart failure, and the future of MMPs and their cleavage products as targets for prevention of post-MI heart failure.",
keywords = "Fibrosis, Heart failure, Inflammation, Matrix metalloproteinases, Myocardial infarction, Omics",
author = "DeLeon-Pennell, {Kristine Y.} and Meschiari, {Cesar A.} and Mira Jung and Lindsey, {Merry L.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/bs.pmbts.2017.02.001",
language = "English (US)",
series = "Progress in Molecular Biology and Translational Science",
publisher = "Elsevier B.V.",
pages = "75--100",
booktitle = "Progress in Molecular Biology and Translational Science",

}

TY - CHAP

T1 - Matrix Metalloproteinases in Myocardial Infarction and Heart Failure

AU - DeLeon-Pennell, Kristine Y.

AU - Meschiari, Cesar A.

AU - Jung, Mira

AU - Lindsey, Merry L.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Cardiovascular disease is the leading cause of death, accounting for 600,000 deaths each year in the United States. In addition, heart failure accounts for 37% of health care spending. Matrix metalloproteinases (MMPs) increase after myocardial infarction (MI) and correlate with left ventricular dysfunction in heart failure patients. MMPs regulate the remodeling process by facilitating extracellular matrix turnover and inflammatory signaling. Due to the critical role MMPs play during cardiac remodeling, there is a need to better understand the pathophysiological mechanism of MMPs, including the biological function of the downstream products of MMP proteolysis. Future studies developing new therapeutic targets that inhibit specific MMP actions to limit the development of heart failure post-MI are warranted. This chapter focuses on the role of MMPs post-MI, the efficiency of MMPs as biomarkers for MI or heart failure, and the future of MMPs and their cleavage products as targets for prevention of post-MI heart failure.

AB - Cardiovascular disease is the leading cause of death, accounting for 600,000 deaths each year in the United States. In addition, heart failure accounts for 37% of health care spending. Matrix metalloproteinases (MMPs) increase after myocardial infarction (MI) and correlate with left ventricular dysfunction in heart failure patients. MMPs regulate the remodeling process by facilitating extracellular matrix turnover and inflammatory signaling. Due to the critical role MMPs play during cardiac remodeling, there is a need to better understand the pathophysiological mechanism of MMPs, including the biological function of the downstream products of MMP proteolysis. Future studies developing new therapeutic targets that inhibit specific MMP actions to limit the development of heart failure post-MI are warranted. This chapter focuses on the role of MMPs post-MI, the efficiency of MMPs as biomarkers for MI or heart failure, and the future of MMPs and their cleavage products as targets for prevention of post-MI heart failure.

KW - Fibrosis

KW - Heart failure

KW - Inflammation

KW - Matrix metalloproteinases

KW - Myocardial infarction

KW - Omics

UR - http://www.scopus.com/inward/record.url?scp=85015398348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015398348&partnerID=8YFLogxK

U2 - 10.1016/bs.pmbts.2017.02.001

DO - 10.1016/bs.pmbts.2017.02.001

M3 - Chapter

C2 - 28413032

AN - SCOPUS:85015398348

T3 - Progress in Molecular Biology and Translational Science

SP - 75

EP - 100

BT - Progress in Molecular Biology and Translational Science

PB - Elsevier B.V.

ER -